联合使用QRISK3与SCORE2可提高对强直性脊柱炎高心血管风险患者的识别:CARMA项目队列随访7.5年结果
在西班牙CARMA项目684例无心血管事件史的强直性脊柱炎患者中,回顾性验证QRISK3、SCORE、mSCORE EULAR 2015/2016和SCORE2的预测价值。随访7.5年(4907人年)共33例发生心血管事件,线性化率6.73/1000人年(95%CI 4.63, 9.44)。四种量表判别能力均较强,QRISK3与SCORE2联合模型AIC最低(406.70)、BIC最低(415.66),为最佳预测模型。
要点
- QRISK3能正确区分心血管风险高低,但7.5年累积事件百分比明显低于QRISK3预期。
- mSCORE EULAR 2015/2016判别能力与SCORE相同,但预测事件百分比明显高于实际事件。
- QRISK3联合SCORE2的模型AIC 406.70、BIC 415.66最低,为最佳预测模型。
核心结论
- 在西班牙CARMA项目患者中,四种算法均能准确区分强直性脊柱炎患者的心血管风险高低。
- QRISK3与SCORE2联合模型兼具QRISK3的最佳判别能力和SCORE2的最佳校准度。
研究设计与样本
- 回顾性分析西班牙前瞻性CARdiovascular in ReuMAtology(CARMA)项目中684例强直性脊柱炎患者,基线时无心血管事件史,于三级中心风湿科门诊随访7.5年,使用基线数据回顾性验证风险图表算法。
主要发现
- 随访4907人年,33例强直性脊柱炎患者发生心血管事件,线性化率6.73/1000人年(95%CI 4.63, 9.44)。
- 四种心血管风险量表之间强相关,QRISK3能正确区分心血管风险高低,但7.5年累积事件百分比明显低于QRISK3预期。
- mSCORE EULAR 2015/2016判别能力与SCORE相同,但预测事件百分比明显高于实际事件。
- SCORE2对心血管风险也有强判别能力,QRISK3与任何其他量表联合均改善模型,其中QRISK3联合SCORE2的AIC最低(406.70)、BIC最低(415.66),为最佳预测模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To establish the predictive value of the QRESEARCH risk estimator version 3 (QRISK3) algorithm in identifying Spanish patients with ankylosing spondylitis (AS) at high risk of cardiovascular (CV) events and CV mortality. We also sought to determine whether to combine QRISK3 with another CV risk algorithm: the traditional SCORE, the modified SCORE (mSCORE) EULAR 2015/2016 or the SCORE2 may increase the identification of AS patients with high-risk CV disease. METHODS: Information of 684 patients with AS from the Spanish prospective CARdiovascular in ReuMAtology (CARMA) project who at the time of the initial visit had no history of CV events and were followed in rheumatology outpatient clinics of tertiary centers for 7.5 years was reviewed. The risk chart algorithms were retrospectively tested using baseline data. RESULTS: After 4,907 years of follow-up, 33 AS patients had experienced CV events. Linearized rate=6.73 per 1000 person-years (95 % CI: 4.63, 9.44). The four CV risk scales were strongly correlated. QRISK3 correctly discriminated between people with lower and higher CV risk, although the percentage of accumulated events over 7.5 years was clearly lower than expected according to the risk established by QRISK3. Also, mSCORE EULAR 2015/2016 showed the same discrimination ability as SCORE, although the percentage of predicted events was clearly higher than the percentage of actual events. SCORE2 also had a strong discrimination capacity according to CV risk. Combining QRISK3 with any other scale improved the model. This was especially true for the combination of QRISK3 and SCORE2 which achieved the lowest AIC (406.70) and BIC (415.66), so this combination would be the best predictive model. CONCLUSIONS: In patients from the Spanish CARMA project, the four algorithms tested accurately discriminated those AS patients with higher CV risk and those with lower CV risk. Moreover, a model that includes QRISK3 and SCORE2 combined the best discrimination ability of QRISK3 with the best calibration of SCORE2.
引用
- Polo Y la Borda J, Castañeda S, Sánchez-Alonso F, et al. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up. Semin Arthritis Rheum. 2024. PMID: 38555727. doi:10.1016/j.semarthrit.2024.152442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。